MTHFR and breast carcinoma: Regarding the mechanism, some studies have indicated that low-dose folic acid supplementation caused by MTHFR genotypes 677C> T reduce serum homocysteine levels but increases glucose concentrations [28]; unfortunately, insulin resistance has been found to be significantly associated with tumor progression in luminal B subtype breast cancer in postmenopausal women [29].